Innovative Research is pleased to announce the availability of COVID-19 Non-Placebo Vaccine Positive samples as well confirmed negative samples that are designed for use in a wide range of research applications, including assay development.
Please be aware that available stock will be sold on a first-come basis. You can email firstname.lastname@example.org to request a database of available samples that includes full details, including IgG antibody results.
COVID-19 vaccine positive status has been confirmed via SARS-CoV-2 IgG antibody assay through negative pre- trial blood draw results and positive post booster tests. This plasma is suitable for use of vNT assay development, among other research applications.
Our SARS-CoV-2 IgG Seroconversion ELISA Kit is specific to the RBD of the spike protein, ensuring high sensitivity and specificity and is suitable for clinical/diagnostic applications. We also offer the Recombinant SARS-CoV-2 Spike Protein RBD.